Showing results (21-30 of 167) with videos related to

Sort By:
Pageof 17
International Journal of MS Care|November 5, 2019
Association of Unemployment and Informal Care with Stigma in Multiple Sclerosis: Evidence from the Survey on Living with Neurological Conditions in CanadaCelestin Hategeka, Anthony L Traboulsee, Katrina McMullen, et al.
BMC Health Services Research|April 2, 2011
Agreement between aggregate and individual-level measures of income and education: a comparison across three patient groupsCarlo A Marra, Larry D Lynd, Stephanie S Harvard, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 15, 2007
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major traumaLarry D Lynd, Ron Goeree, Mark A Crowther, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 19, 2012
Cost-effectiveness of using a molecular diagnostic test to improve preoperative diagnosis of thyroid cancerMehdi Najafzadeh, Carlo A Marra, Larry D Lynd, et al.
Thorax|November 28, 2013
Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based studyMohsen Sadatsafavi, Larry D Lynd, Carlo A Marra, et al.
Health Policy (Amsterdam, Netherlands)|February 3, 2015
Why orphan drug coverage reimbursement decision-making needs patient and public involvementConor M W Douglas, Elizabeth Wilcox, Michael Burgess, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|July 27, 2007
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major traumaLarry D Lynd, Ron Goeree, Mark A Crowther, et al.
Rheumatology (Oxford, England)|March 3, 2020
Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: a systematic review and meta-analysis of observational studiesNicole W Tsao, Nevena Rebic, Larry D Lynd, et al.
Pharmacoeconomics|November 5, 2020
Evaluating New Zealanders' Values for Drug Coverage Decision Making: Trade-Offs between Treatments for Rare and Common ConditionsLinda Yamoah, Nick Dragojlovic, Alesha Smith, et al.
BMJ Global Health|October 15, 2020
Use of interrupted time series methods in the evaluation of health system quality improvement interventions: a methodological systematic reviewCelestin Hategeka, Hinda Ruton, Mohammad Karamouzian, et al.
Pageof 17